The lab has received a grant from the MPN Research Foundation focused on identifying approaches to leverage NFkB pathway dysregulation for therapeutic benefit in myeloproliferative neoplasms.
The lab has received a grant from the MPN Research Foundation focused on identifying approaches to leverage NFkB pathway dysregulation for therapeutic benefit in myeloproliferative neoplasms.
1 Comment
Luis El Loco
9/12/2017 02:16:12 pm
Oh WOW, congrats Steve, this is so amazing. very proud of you!
Reply
Leave a Reply. |
|